IRIS Accounts Production v24.3.2.46 13291685 Board of Directors 1.6.23 31.5.24 31.5.24 0 0 false true false false true false Fair value model iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh132916852023-05-31132916852024-05-31132916852023-06-012024-05-31132916852022-03-31132916852022-04-012023-05-31132916852023-05-3113291685ns15:EnglandWales2023-06-012024-05-3113291685ns14:PoundSterling2023-06-012024-05-3113291685ns10:Director12023-06-012024-05-3113291685ns10:PrivateLimitedCompanyLtd2023-06-012024-05-3113291685ns10:SmallEntities2023-06-012024-05-3113291685ns10:AuditExempt-NoAccountantsReport2023-06-012024-05-3113291685ns10:SmallCompaniesRegimeForDirectorsReport2023-06-012024-05-3113291685ns10:SmallCompaniesRegimeForAccounts2023-06-012024-05-3113291685ns10:FullAccounts2023-06-012024-05-3113291685ns10:Director22023-06-012024-05-3113291685ns10:RegisteredOffice2023-06-012024-05-3113291685ns5:CurrentFinancialInstruments2024-05-3113291685ns5:CurrentFinancialInstruments2023-05-3113291685ns5:Non-currentFinancialInstruments2024-05-3113291685ns5:Non-currentFinancialInstruments2023-05-3113291685ns5:ShareCapital2024-05-3113291685ns5:ShareCapital2023-05-3113291685ns5:RetainedEarningsAccumulatedLosses2024-05-3113291685ns5:RetainedEarningsAccumulatedLosses2023-05-3113291685ns5:WithinOneYearns5:CurrentFinancialInstruments2024-05-3113291685ns5:WithinOneYearns5:CurrentFinancialInstruments2023-05-3113291685ns5:Secured2024-05-3113291685ns5:Secured2023-05-31
REGISTERED NUMBER: 13291685 (England and Wales)














UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MAY 2024

FOR

AL PHARMA HOLDINGS LTD

AL PHARMA HOLDINGS LTD (REGISTERED NUMBER: 13291685)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2024




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 3


AL PHARMA HOLDINGS LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MAY 2024







DIRECTORS: D Ghelani
B Radia





REGISTERED OFFICE: 5 Jardine House
Harrovian Business Village
Bessborough Road
Harrow
Middlesex
HA1 3EX





REGISTERED NUMBER: 13291685 (England and Wales)





ACCOUNTANTS: David Simon Limited
Chartered Certified Accountants
5 Jardine House
Harrovian Business Village
Bessborough Road
Harrow
Middlesex
HA1 3EX

AL PHARMA HOLDINGS LTD (REGISTERED NUMBER: 13291685)

STATEMENT OF FINANCIAL POSITION
31 MAY 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Investment property 4 5,310,269 4,781,495

CURRENT ASSETS
Debtors 5 18,675 95,427
Cash at bank 264 2,849
18,939 98,276
CREDITORS
Amounts falling due within one year 6 175,869 215,756
NET CURRENT LIABILITIES (156,930 ) (117,480 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

5,153,339

4,664,015

CREDITORS
Amounts falling due after more than one
year

7

5,538,628

4,953,938
NET LIABILITIES (385,289 ) (289,923 )

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings (385,389 ) (290,023 )
SHAREHOLDERS' FUNDS (385,289 ) (289,923 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 24 February 2025 and were signed on its behalf by:





D Ghelani - Director


AL PHARMA HOLDINGS LTD (REGISTERED NUMBER: 13291685)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2024

1. STATUTORY INFORMATION

AL Pharma Holdings Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Going concern
Notwithstanding the deficit of assets at the balance sheet date these financial statements have been prepared on the going concern basis on the basis that the group companies shall support the company until it returns to a net assets position. The directors consider that it is appropriate to prepare the accounts on the going concern basis.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

4. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 1 June 2023 4,781,495
Additions 528,774
At 31 May 2024 5,310,269
NET BOOK VALUE
At 31 May 2024 5,310,269
At 31 May 2023 4,781,495

No changes in fair value of investment property from last year as per the directors.

AL PHARMA HOLDINGS LTD (REGISTERED NUMBER: 13291685)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MAY 2024

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Other debtors 18,675 95,427

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts 94,928 87,400
Trade creditors 69,369 128,356
Other creditors 11,572 -
175,869 215,756

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2024 2023
£    £   
Bank loans 2,084,231 2,171,961
Amounts owed to group undertakings 3,454,397 2,781,977
5,538,628 4,953,938

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal - 1,771,729

8. SECURED DEBTS

The following secured debts are included within creditors:

2024 2023
£    £   
Bank loans 2,179,159 2,259,361

The bank loan is secured by way of a fixed and floating charge over the investment property and contains a negative pledge.